Figure 2.
Post-hematopoietic cell transplantation (HCT) outcomes for 506 adults with acute myeloid leukemia and initial abnormal cytogenetics undergoing allogeneic HCT while in first or second morphologic remission, stratified by both pre-HCT cytogenetics and pre-HCT multiparameter flow cytometry. (A) Cumulative incidence of relapse, (B) relapse-free survival, (C) overall survival, and (D) cumulative incidence of non-relapse mortality. Cyto N: normal cytogenetics; Cyto AbN: abnormal cytogenetics; MFC: multiparameter flow cytometry.